General Information |
| Clinical trials phase |
Phase 2 |
| Start date (estimated) |
2025-09-01 |
| End date (estimated) |
2026-12-30 |
| Clinical feature |
| Label |
Ischemic Stroke |
| Link |
http://purl.obolibrary.org/obo/NCIT_C95802 |
| Description |
An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue. |
|
Administrative Information |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2500108390 |
| Other study identifiers |
| Name |
ChiCTR2500108390 |
| Description |
Chinese Clinical Trial Registry |
|
| Source weblink |
https://www.chictr.org.cn/showproj.html?proj=276290 |
| Sponsors |
Neurosurgery Department of Seventh Medical Center, Senior Department of Neurosurgery, the First Medical Center of PLA General Hospital
|
Cells |
| Which differentiated cell type is used |
| Label |
neural progenitor cell |
| Link |
http://purl.obolibrary.org/obo/CL_0011020 |
| Description |
An undifferentiated cell derived from a neural stem cell, with a limited capacity to self-renew (Dibajnia and Morshead, 2013) and the ability to generate multiple types of lineage-restricted progenitors, contributing to the formation of neurons, astrocytes, and oligodendrocytes. |
|
Recruitment |
| Recruitment Status |
Not yet recruiting |
| Comment recruitment status |
low-dose cohort:5;mid-dose cohort:5;high-dose cohort:5;sham operation group:6; |
| Estimated number of participants |
21 |
| Contact institutions/departments |
|
